Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer
Open Access
- 23 November 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (50), 20090-20094
- https://doi.org/10.1073/pnas.1117772108
Abstract
Estrogen receptor β (ERβ) is activated in the prostate by 5α-androstane-3β,17β-diol (3β-Adiol) where it exerts antiproliferative activity. The proliferative action of the androgen receptor is activated by 5α-dihydrotestosterone (DHT). Thus, prostate growth is governed by the balance between androgen receptor and ERβ activation. 3β-Adiol is a high-affinity ligand and agonist of ERβ and is derived from DHT by 3-keto reductase/3β-hydroxysteroid dehydrogenase enzymes. Here, we demonstrate that, when it is expressed in living cells containing an estrogen response element-luciferase reporter, 17β-hydroxysteroid dehydrogenase type 6 (17βHSD6) converts the androgen DHT to the estrogen 3β-Adiol, and this leads to activation of the ERβ reporter. This conversion of DHT occurs at concentrations that are in the physiological range of this hormone in the prostate. Immunohistochemical analysis revealed that 17βHSD6 is expressed in ERβ-positive epithelial cells of the human prostate and that, in prostate cancers of Gleason grade higher than 3, both ERβ and 17βHSD6 are undetectable. Both proteins were present in benign prostatic hyperplasia samples. These observations reveal that formation of 3β-Adiol via 17βHSD6 from DHT is an important growth regulatory pathway that is lost in prostate cancer.Keywords
This publication has 27 references indexed in Scilit:
- An ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated InflammationCell, 2011
- CYP7B1: One Cytochrome P450, Two Human Genetic Diseases, and Multiple Physiological FunctionsJournal of Biological Chemistry, 2009
- Estrogen Receptors: How Do They Signal and What Are Their TargetsPhysiological Reviews, 2007
- Role of Microsomal Retinol/Sterol Dehydrogenase-Like Short-Chain Dehydrogenases/Reductases in the Oxidation and Epimerization of 3α-Hydroxysteroids in Human TissuesEndocrinology, 2007
- Estrogen Receptor (ER) β Modulates ERα-Mediated Transcriptional Activation by Altering the Recruitment of c-Fos and c-Jun to Estrogen-Responsive PromotersMolecular Endocrinology, 2006
- Human Cytosolic 3α-Hydroxysteroid Dehydrogenases of the Aldo-keto Reductase Superfamily Display Significant 3β-Hydroxysteroid Dehydrogenase ActivityJournal of Biological Chemistry, 2004
- Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1‒AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormonesBiochemical Journal, 2000
- Expression Cloning and Characterization of Oxidative 17β- and 3α-Hydroxysteroid Dehydrogenases from Rat and Human ProstatePublished by Elsevier BV ,1997
- Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditismNature, 1991
- Determination of Nonconjugated and Conjugated Steroid Levels in Plasma and Prostate after Separation on C‐18 ColumnsAnnals of the New York Academy of Sciences, 1990